Buy Clenbuterol 50ml Injection Online

Clenbuterol 50ml Injection is an injectable veterinary formulation containing clenbuterol hydrochloride, a beta-2 adrenergic agonist used in certain veterinary respiratory-management contexts. In authorized equine products, clenbuterol is used as a bronchodilator to help address airway obstruction associated with bronchospasm and respiratory disease.

The 50ml presentation is documented for authorized clenbuterol injectable products, including Ventipulmin Solution for Injection 30 micrograms/ml. European veterinary medicine records identify clenbuterol hydrochloride as the active substance, horses as the target species, intravenous administration, and prescription-only veterinary status for this type of product.

Because the name “Clenbuterol 50ml Injection” does not by itself establish a particular manufacturer, concentration, registration status, or formulation, the product label supplied with the specific vial should always be checked before use.

What Is Clenbuterol 50ml Injection?

Clenbuterol 50ml Injection refers to an injectable veterinary medicine containing clenbuterol hydrochloride. Clenbuterol belongs to the beta-2 adrenergic agonist class and has bronchodilator activity. In veterinary medicine, authorized equine formulations have been used in the management of respiratory disorders where bronchial constriction and airway obstruction are clinically relevant.

An authorized European product, Ventipulmin Solution for Injection 30 micrograms/ml, contains 30 micrograms of clenbuterol hydrochloride per millilitre and is supplied in a 50ml vial. The European Union Veterinary Medicines Information database identifies horses as the target species and intravenous use as the authorized route for that product. It is also classified as a veterinary prescription medicine.

Other authorized products with the same active ingredient and presentation exist in different jurisdictions. For example, Spasmobronchal 0.03 mg/ml is documented as a 50ml injectable equine product containing clenbuterol hydrochloride.

These products demonstrate why it is important to distinguish the active ingredient and presentation from the exact branded product. Concentration, excipients, approved species, indications, route, withdrawal requirements and legal status can vary between products and jurisdictions.

Product Overview

The table above reflects information documented for authorized clenbuterol injectable veterinary products and should not be interpreted as confirmation that every product sold under the generic description has identical specifications.

Active Ingredient: Clenbuterol Hydrochloride

Clenbuterol hydrochloride is a beta-2 adrenergic agonist with bronchodilator properties. Its pharmacological activity can relax bronchial smooth muscle, helping increase airway diameter.

The South African National Horseracing Authority describes clenbuterol hydrochloride as a beta-2 adrenergic agonist bronchodilator that acts on receptors in the lungs and relaxes muscles of the lower small airways.

For equine veterinary products, this pharmacological action is particularly relevant where airway narrowing, bronchospasm or mucus-associated obstruction contributes to respiratory difficulty.

The exact strength, excipients and formulation should nevertheless be taken from the label of the individual product. For example, the current UK veterinary documentation for Ventipulmin Solution for Injection identifies 30 micrograms of clenbuterol hydrochloride per ml and 10mg benzyl alcohol per ml.

Key Features of Clenbuterol 50ml Injection

Depending on the specific authorized formulation, Clenbuterol 50ml Injection may offer the following product characteristics:

• 50ml injectable presentation
• Clenbuterol hydrochloride as the active substance
• Beta-2 adrenergic agonist activity
• Bronchodilator action
• Veterinary formulation intended for animal treatment
• Equine respiratory applications for authorized products
• Prescription veterinary status in jurisdictions where applicable
• Clearly defined concentration on the product label
• Batch and expiry information for product traceability

One documented 50ml product, Ventipulmin Solution for Injection 30 micrograms/ml, is specifically authorized for horses and intended for treatment of obstructive respiratory disease.

Clenbuterol in Equine Veterinary Medicine

Clenbuterol has an established veterinary role in respiratory medicine. Authorized equine products have been used where bronchospasm and airway obstruction contribute to respiratory disease.

The documented indications for Ventipulmin Solution for Injection include obstructive respiratory disease in horses. The associated UK product documentation describes its indication as treatment of obstructive respiratory disease in horses.

Veterinary respiratory conditions can involve several interacting factors, including:

• Bronchial smooth-muscle constriction
• Airway inflammation
• Excess mucus
• Increased airway resistance
• Allergic or hypersensitivity responses
• Infectious respiratory disease

Clenbuterol does not replace diagnosis of the underlying respiratory condition. A veterinarian may need to determine whether airway obstruction is caused by inflammatory, allergic, infectious or other processes and whether bronchodilator treatment is appropriate.

The South African National Horseracing Authority specifically states that clenbuterol use should be limited to horses with a documented clinical diagnosis of airway disease indicating the need for therapeutic treatment.

Respiratory Applications

Authorized injectable clenbuterol products can be used in veterinary respiratory management where bronchospasm contributes to airway obstruction.

Documented product information for Ventipulmin identifies respiratory disease involving airway obstruction as the therapeutic context. Other product information describes applications involving bronchial spasm, cough and dyspnea associated with bronchoconstriction, bronchitis and chronic obstructive pulmonary disease.

Respiratory treatment should always begin with appropriate veterinary assessment. Signs such as coughing, increased respiratory effort, nasal discharge or reduced exercise tolerance can have numerous causes, and a bronchodilator is not appropriate for every respiratory problem.

Where infection is involved, treatment may require additional veterinary management rather than relying on bronchodilation alone.

Product Form and 50ml Presentation

The 50ml presentation is particularly important when identifying an injectable clenbuterol product because several different formulations and concentrations exist.

For example, the European veterinary medicines database records Ventipulmin Solution for Injection as:

• Clenbuterol hydrochloride: 30 micrograms/ml
• Pharmaceutical form: solution for injection
• Package: 50ml amber glass vial
• Target species: horse
• Route: intravenous
• Supply status: veterinary prescription medicine.

The same database also records equivalent 50ml presentations in other European markets.

This means buyers should not assume that every “Clenbuterol 50ml Injection” product has the same concentration. The vial label and current approved product information should always take priority.

Veterinary Supervision and Administration

Clenbuterol injection is a prescription veterinary medicine in documented authorized products, and administration should be performed according to the applicable product label and veterinary direction.

For example, the authorized Ventipulmin injectable formulation is documented for intravenous use in horses.

Because injectable medicines require appropriate handling and administration technique, Clenbuterol 50ml Injection should not be treated like an ordinary supplement or over-the-counter wellness product.

This page intentionally does not provide an individualized dosing schedule. The appropriate dose, frequency and treatment duration depend on the specific registered formulation, animal, diagnosis and veterinary instructions.

Safety and Precautions

Clenbuterol has clinically significant pharmacological effects and should be used carefully.

The South African National Horseracing Authority identifies potential adverse effects including:

• Increased heart rate
• Sweating
• Muscle tremors

It also notes potential longer-term concerns involving bone strength, the immune system and cardiac muscle.

Veterinary product information should therefore be reviewed carefully before treatment.

Particular attention may be required where a horse has a history of cardiovascular disease or other conditions that could make beta-2 agonist effects clinically significant.

The veterinarian should also be informed about other medicines, supplements and treatments the horse is receiving.

Important Handling Precautions

The UK product documentation for injectable Ventipulmin identifies clenbuterol as a beta-agonist and provides precautions concerning skin and eye contact. It recommends thorough washing after contact and appropriate first-aid measures in the event of accidental exposure.

As with other injectable veterinary medicines:

• Keep the product away from children.
• Do not use beyond the stated expiry date.
• Check the vial for damage or contamination.
• Follow the specific product’s storage requirements.
• Follow veterinary instructions for administration.
• Dispose of unused medicine according to applicable requirements.

Pregnancy and Lactation Considerations

Clenbuterol can affect smooth muscle and uterine activity. Consequently, pregnancy and the stage of gestation are important considerations.

Veterinary product information for injectable clenbuterol warns about use in pregnant mares close to foaling because of its ability to inhibit uterine contractions.

The specific product label should therefore be reviewed before use in pregnant or lactating animals.

Milk restrictions can also apply. For example, the documented Ventipulmin injectable information states that it should not be used in animals producing milk for human consumption.

Competition and Medication-Control Considerations

This is an especially important consideration for horses involved in racing or regulated competition.

Clenbuterol is subject to medication-control requirements that can differ between jurisdictions and organizations. The South African National Horseracing Authority identifies clenbuterol as a substance subject to specific therapeutic-use requirements and states that its use must be connected to a documented clinical diagnosis and veterinary treatment records.

The same guidance notes that clenbuterol has metabolic effects that can raise concerns regarding potential performance-enhancing use.

Therefore, Clenbuterol 50ml Injection should not be marketed or represented as a performance-enhancing product, racing aid or competition shortcut.

Anyone responsible for a competition horse should check the rules of the relevant governing body and obtain appropriate veterinary guidance before treatment.

Medication-control rules can change, and a product being legally authorized for veterinary treatment does not automatically mean that its use is permitted during competition.

Storage and Handling

Storage requirements depend on the exact formulation.

For the currently documented Ventipulmin Solution for Injection, the UK product information states:

• Do not store above 25°C.
• Protect from light.
• Keep the product in its outer carton.
• Follow the specified in-use period after opening.
• Discard unused material after the applicable in-use period.

These requirements should not automatically be transferred to another Clenbuterol 50ml Injection product. Always follow the storage instructions printed on the actual product packaging.

Proper storage helps protect product quality and supports appropriate veterinary medicine handling.

Regulatory Considerations

Clenbuterol products are regulated differently across countries.

The European Union Veterinary Medicines Information database currently lists Ventipulmin Solution for Injection 30 micrograms/ml as an authorized veterinary medicine in Ireland, with horses as the target species and veterinary prescription status.

Other European records similarly identify 50ml clenbuterol injectable products as prescription veterinary medicines.

In South Africa, the National Horseracing Authority has specific guidance governing therapeutic clenbuterol use in racing horses. Its current guidance states that only the specified registered Ventipulmin granules may be administered under its racing protocol and that compounded medications are not permitted under that protocol.

These examples demonstrate why regulatory status should be checked according to:

1. The exact product.
2. The product’s manufacturer.
3. The country where it is marketed.
4. The animal species.
5. The intended use.
6. Applicable veterinary-prescription requirements.
7. Competition or medication-control rules where relevant.

Purchasing Clenbuterol 50ml Injection

When reviewing Clenbuterol 50ml Injection, customers should verify the product information rather than relying solely on the product name.

Important details include:

• Active ingredient
• Concentration
• Volume
• Manufacturer
• Batch number
• Expiry date
• Product registration information
• Target species
• Route of administration
• Storage requirements
• Prescription status
• Country-specific restrictions

A 50ml vial containing 30 micrograms/ml clenbuterol hydrochloride is a documented presentation for authorized equine injectable products, but this does not mean that every product labelled “Clenbuterol 50ml Injection” has the same specifications.

Customers should also confirm that the product can legally be supplied and received in their destination country.

Where To Buy Clenbuterol 50ml Injection Online

Clenbuterol 50ml Injection should only be purchased through a lawful veterinary medicine supply channel where the product is authorized or legally available.

Availability, prescription requirements, import rules and permitted uses vary between countries. A product being available online does not by itself establish that it is authorized for importation or veterinary use in every destination.

Before ordering, customers should verify:

• Whether clenbuterol veterinary medicines are authorized in their country.
• Whether a veterinary prescription is required.
• Whether the specific formulation is permitted for the intended animal.
• Whether additional import documentation applies.
• Whether competition or racing regulations affect its use.
• Whether the product information matches the formulation being offered.

World Equine Vet should provide clear product information and should not represent a regulated veterinary medicine as universally available where local laws may restrict its sale, possession, importation or use.

Frequently Asked Questions

What is Clenbuterol 50ml Injection?

It is a 50ml injectable veterinary presentation containing clenbuterol hydrochloride. Authorized equine products containing clenbuterol are used as beta-2 adrenergic bronchodilators in the management of certain obstructive respiratory conditions.

What is the active ingredient?

The active ingredient is clenbuterol hydrochloride. A documented Ventipulmin injectable product contains 30 micrograms of clenbuterol hydrochloride per millilitre.

Is Clenbuterol 50ml Injection intended for horses?

Authorized products with this presentation include formulations specifically intended for horses. However, the target species must be confirmed from the individual product’s label and registration information.

What is clenbuterol used for in horses?

Authorized veterinary formulations may be used for respiratory conditions involving airway obstruction and bronchospasm. The exact approved indication depends on the registered product and jurisdiction.

Is Clenbuterol 50ml Injection prescription-only?

For documented authorized injectable products such as Ventipulmin, veterinary prescription requirements apply.

Can I use it for a horse without veterinary advice?

Veterinary assessment is important before using clenbuterol because respiratory symptoms can have different causes and the medicine has significant cardiovascular and other pharmacological effects.

Is clenbuterol permitted in horse racing?

Its status depends on the governing jurisdiction and competition rules. The South African National Horseracing Authority has specific therapeutic-use requirements and medication-control provisions for clenbuterol.

Does the 50ml size indicate the concentration?

No. Volume and concentration are separate product characteristics. A documented Ventipulmin injectable product is 50ml at 30 micrograms/ml, but another product should not be assumed to have the same concentration without checking its label.

How should Clenbuterol 50ml Injection be stored?

Storage depends on the exact product. For the documented Ventipulmin injectable formulation, the product information states that it should not be stored above 25°C and should be protected from light.

Can it be used in pregnant mares?

Pregnancy requires particular veterinary consideration because clenbuterol can affect uterine contractions. Product information specifically warns about use close to foaling.

Is Clenbuterol 50ml Injection the same as Ventipulmin?

Not necessarily. Ventipulmin is a specific branded product containing clenbuterol hydrochloride. A generic product described as “Clenbuterol 50ml Injection” may have different manufacturer, formulation, registration and regulatory details.

Final Summary

Clenbuterol 50ml Injection is an injectable veterinary formulation associated with clenbuterol hydrochloride, a beta-2 adrenergic agonist with bronchodilator activity. Authorized 50ml injectable products such as Ventipulmin Solution for Injection 30 micrograms/ml are documented for horses and veterinary treatment of obstructive respiratory disease.

Because clenbuterol is a regulated veterinary medicine with significant pharmacological effects, product identification, veterinary supervision, storage, prescription requirements and medication-control rules all matter. Racing and competition regulations are particularly important, and requirements can differ substantially between jurisdictions.

For World Equine Vet, product information should therefore remain specific, transparent and consistent with the actual manufacturer’s label rather than assuming that every 50ml clenbuterol injection has identical specifications.

clenbuterol 50ml in the treatment of visceral pain associated with colic and in the treatment of inflammation and pain associated with muscrders.uloskeletal diso

is recommended in those cases where corticosteroid therapy is contraindicated

DOSAGE AND HOW TO USE

should be administered to cattle and horses intramuscularly. clenbuterol 50ml
Cattle:  1mL for each 22.5 kg of weight intramuscularly or intravenously. Repeat if necessary, at intervals of 24 hours, but not more than 5 consecutive days.
Horses:  In visceral pain associated with colic, 1mL is recommended for every 45 kg of weight intramuscularly or intravenously, at the onset of symptoms. Treatment can be repeated 1 or 2 times if symptoms reappear.
In inflammation and pain associated with musculoskeletal changes, 1 ml is recommended for every 45 kg of weight, intramuscularly or intravenously, once a day for no more than 5 consecutive days.

PRECAUTIONS

Do not exceed recommended serving. Do not mix other substances in the same syringe. Avoid intra-arterial injection to horses, as they react with ataxia, incoordination, hyperventilation, hysteria and muscle weakness. Precautions should be taken when administering to calves and, if symptoms of dehydration occur, fluid therapy should be performed. Do not use during pregnancy.

CONTRAINDICATIONS

Do not use in animals less than 3 days old. Do not use in horses with a history of hypersensitivity to flunixin.

Cattle: Slaughter: slaughter of animals treated with this product should only be carried out 20 days after the last application. Milk: Milk from animals treated with this product must not be destined for human consumption until 1 day after the last application of this product.
Horses: Slaughter: Do not use in animals whose meat is intended for human consumption.

PRESENTATIONS clenbuterol 50ml
Glass vial containing 50 mL.

WITHDRAWAL PERIOD
Cattle: Slaughter: slaughter of animals treated with this product should only be carried out 20 days after the last application. Milk: Milk from animals treated with this product must not be destined for human consumption until 1 day after the last application of this product.
Horses: Slaughter: Do not use in animals whose meat is intended for human consumption.